Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 5:17 PM
Ignite Modification Date: 2025-12-24 @ 5:17 PM
NCT ID: NCT02436850
Eligibility Criteria: Inclusion Criteria: 1. Patients admitted to internal ward 2. Patients with moderate to large pleural effusion per ultrasound as defined under Eligibility section below 3. At least of the following findings: * Dyspnea on admission notes * Tachypnea (RR \>18 pm) * Desaturation (saturation\<88%) * Admission diagnosis of CHF exacerbation or any uncontrolled heart failure, * Effort dyspnea per history, * Acute or subacute (last two weeks) need for oxygen supplement or Noninvasive ventilation. * Admission diagnosis of pulmonary edema or pulmonary congestion * Hypoxemia (PaO2\<60mmHg) * Pleuritic chest pain Exclusion Criteria: 1. Subject currently enrolled in another investigational study 2. Patients on mechanical ventilation 3. Patients with coagulopathy (known or with any prolongation of PTT, PT, fibrinogen\<200, platelets \<100000) 4. Patients with cognitive impairment who cannot sign informed consent 5. Patients with sepsis or fever and pneumonia and suspected empyema 6. Patients with any previous surgeries to the lungs 7. Patients whom the primary team call for therapeutic TC. 8. Patients with less than moderate amount of pleural effusion (see Eligibility criteria) 9. Palliative patients 10. Pregnant patients 11. On any current anticoagulation therapy or with any abnormal coagulation study. 12. Patients with septations or cavitation in pleural space (visible on US
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT02436850
Study Brief:
Protocol Section: NCT02436850